Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Couch

Showing results (211-220 of 243) with videos related to

Pageof 25
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2011
Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adultsRobert B Couch, Robert L Atmar, Luis M Franco, et al.
The Journal of Infectious Diseases|September 27, 2018
Elevated Human Dipeptidyl Peptidase 4 Expression Reduces the Susceptibility of hDPP4 Transgenic Mice to Middle East Respiratory Syndrome Coronavirus Infection and DiseaseAbdullah Algaissi, Anurodh S Agrawal, Song Han, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1995
Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemiaE Whimbey, R B Couch, J A Englund, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2006
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparationsRobert L Atmar, Wendy A Keitel, Shital M Patel, et al.
Vaccine|July 18, 2009
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humansRobert B Couch, Robert L Atmar, Thomas R Cate, et al.
Lancet (London, England)|October 31, 1981
Ribavirin small-particle aerosol treatment of influenzaV Knight, H W McClung, S Z Wilson, et al.
The Journal of Infectious Diseases|April 6, 2006
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adultsJohn J Treanor, Gilbert M Schiff, Robert B Couch, et al.
Vaccine|December 1, 1995
Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humansE D Kilbourne, R B Couch, J A Kasel, et al.
BMC Infectious Diseases|August 1, 2014
Superior antigen-specific CD4+ T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and olderRobert B Couch, José M Bayas, Covadonga Caso, et al.
The New England Journal of Medicine|March 30, 2002
Clinical responses to undiluted and diluted smallpox vaccineSharon E Frey, Robert B Couch, Carol O Tacket, et al.
Pageof 25

Showing results (211-220 of 243) with videos related to

Sort By:
Pageof 25
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 15, 2011
Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adultsRobert B Couch, Robert L Atmar, Luis M Franco, et al.
The Journal of Infectious Diseases|September 27, 2018
Elevated Human Dipeptidyl Peptidase 4 Expression Reduces the Susceptibility of hDPP4 Transgenic Mice to Middle East Respiratory Syndrome Coronavirus Infection and DiseaseAbdullah Algaissi, Anurodh S Agrawal, Song Han, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1995
Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemiaE Whimbey, R B Couch, J A Englund, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2006
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparationsRobert L Atmar, Wendy A Keitel, Shital M Patel, et al.
Vaccine|July 18, 2009
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humansRobert B Couch, Robert L Atmar, Thomas R Cate, et al.
Lancet (London, England)|October 31, 1981
Ribavirin small-particle aerosol treatment of influenzaV Knight, H W McClung, S Z Wilson, et al.
The Journal of Infectious Diseases|April 6, 2006
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adultsJohn J Treanor, Gilbert M Schiff, Robert B Couch, et al.
Vaccine|December 1, 1995
Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humansE D Kilbourne, R B Couch, J A Kasel, et al.
BMC Infectious Diseases|August 1, 2014
Superior antigen-specific CD4+ T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and olderRobert B Couch, José M Bayas, Covadonga Caso, et al.
The New England Journal of Medicine|March 30, 2002
Clinical responses to undiluted and diluted smallpox vaccineSharon E Frey, Robert B Couch, Carol O Tacket, et al.
Pageof 25